Bioethics Debate: Ethics of U Penn surgical “drug implant” experiment

Bioethics Debate: Ethics of U Penn Surgical “Drug Implant” Experiment This debate between AHRP President, Vera Sharav and Bioethicist, Paul Root Volpe, Ph.D., University of Pennsylvania, was prompted by an October 7 infomail. The reasons for AHRP’s opposition to drug implants for psychiatric patients are explained here: https://ahrp.org/ahrpspeaks/drugimplant1103.php —–Original Message—–…

How to Quit the Cure–Antidepressant Withdrawal – NewsWeek

How to Quit the Cure–Antidepressant Withdrawal – NewsWeek Wed Aug 3, 2005 The current issue of NEWSWEEK lets readers in on the dirty little secret about the prescribed antidepressants of the SSRI variety. Although psychiatrists shudder at calling a spade a spade, these prescribed drugs are physically addictive–as is evident…

Penn Psychiatrist Files Whistleblower Lawsuit – Investigtion Confirms Medicare Chief Lied

Philadelphia Daily News Pharma Influence: Penn Psychiatrist Files Whistleblower Lawsuit – Investigtion Confirms Medicare Chief Lied to Congress Wed, 7 Jul 2004 “Drug companies not only write checks to hospitals, they write checks to politicians…They write checks to both sides of the aisle.” Two separate news reports provide a glimpse…

Children and antidepressants – CNN Financial Today

Children and antidepressants – CNN Financial Today Fri, 12 Nov 2004 When CNN was looking for an expert with a responsible, balanced view about the concerns of prescribing psychotropic drugs for children, they turned to AHRP. We recommended psychiatrist, Dr. Joseph Glenmullen, a practicing clinician and Harvard faculty member, whose…

FDA Bad Faith – Daniel Troy’s pre-emption defense – Nat’l Law Journal

FDA Bad Faith – Daniel Troy’s pre-emption defense – Nat’l Law Journal Fri, 26 Mar 2004 Federal regulations require drug label warnings if there is “reasonable evidence” of a link between adverse effects and drug action. An article in the National Law Journal shows how s FDA’s chief counsel, Daniel…

Prozac Revisited: Concerns About Suicides Surface – Boston Globe

Prozac Revisited: Concerns About Suicides Surface – Boston Globe Eli Lilly’s denial about the risk of suicide for some patients prescribed Prozac was the subject of a series of reports in the Boston Globe. The article (Sunday, June 11) revealed the irony behind the duplicity. Dr. Martin Teicher, who first…

FDA Issues Public Health Advisory Entitled Reports Of Suicidality in Pediatric

FDA Issues Public Health Advisory Entitled Reports Of Suicidality in Pediatric Mon, 27 Oct 2003 The FDA issued a warning about the suicide risk for children prescribed an antidepressant of the SSRI class. These drugs have never been shown to be more effective than placebo for the treatment of depression–which…

GSK Sales Reps told NOT to Divulge Paxil Data / Merck Withdraws Vioxx

GSK Sales Reps told NOT to Divulge Paxil Data / Merck Withdraws Vioxx Thu, 30 Sep 2004 The Associated Press reports: “Merck pulled Vioxx after admitting studies showed the drug raised the risk of heart attack. As recently as August, Merck “strongly” disagreed with studies showing the drug increased heart…

Article

Letter from David Healy, MD to Peter J. Pitts Executive Summary of suicidal evidence not addressed by FDA In the light of Traci Johnson’s death on February 7th 2004, will FDA obtain Pfizer’s entire folder on the 1982 Hindmarch study in which healthy volunteers were given Zoloft, and make a…

Are we all going mad, or are the experts crazy? / Are psychiatric drugs an assault on the human condition?

Are we all going mad, or are the experts crazy? / Are psychiatric drugs an assault on the human condition? Fri, 19 Aug 2005 Below, two companion pieces: An Op Ed in the Los Angeles Times, by Stuart Kirk, a professor of social welfare at UCLA, addresses psychiatry’s conundum: the…

Janssen Admits Hiding Risperdal Risks / TMAP & Illinois Mental Health Screening

Janssen Pharma Admits Hiding Risperdal Drug Risks / TMAP & Illinois Mental Health Screening Plan Sat, 24 Jul 2004 The Miami Herald reports (below) that in a letter to doctors, Janssen Pharmacia, manufacturer of the highly promoted drug, Risperdal (risperidone), admitted “misleading doctors and other healthcare providers about the safety…